Müller, A-C <br/><br/>
Toxicity and outcome of pelvic IMRT for node-positive prostate cancer.  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Nov 2012 
 - 982-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1439-099X 
<br/><br/><label>Standard No.: </label>10.1007/s00066-012-0169-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Combined Modality Therapy<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymph Node Excision<br/>Lymphatic Metastasis--pathology<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Neoplasm Grading<br/>Neoplasm Staging<br/>Positron-Emission Tomography<br/>Prostate-Specific Antigen--blood<br/>Prostatectomy<br/>Prostatic Neoplasms--mortality<br/>Radiation Injuries--etiology<br/>Radiotherapy Dosage<br/>Radiotherapy, Adjuvant<br/>Radiotherapy, Intensity-Modulated--adverse effects<br/>Rectum--pathology<br/>Survival Analysis<br/>Tomography, X-Ray Computed<br/>Urinary Bladder--pathology